.png){kind=icon}
返回
Acute Chest Pain
.png){kind=icon}
OA
AI
DOI：10.3238/arztebl.m2023.0065.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Background: Acute chest pain (aCP) can be a symptom of life-threatening diseases such as acute coronary or aortic syndrome, but often has a non-cardiac cause. The recommendations regarding pre-hospital drug treatment of patients with aCP are ambiguous. Methods: A retrospective cohort study was conducted of 822 patients with aCP who were attended by emergency physicians. The cause of aCP was classified as follows: acute coronary syndrome without ST-segment elevation (NSTE-ACS), acute aortic syndrome, hypertensive crisis, cardiac arrhythmias, musculoskeletal, or other. The suspected and discharge diagnoses were compared, and the pre-hospital administration of acetylsalicylic acid (ASA) and unfractionated heparin (UFH) was analyzed. Furthermore, the parameters that improved diagnostic accuracy were investigated. Results: The positive predictive value of the diagnosis assigned by the emergency physician (EP diagnosis) was 39.7%. NSTEACS was the most commonly suspected cause of aCP (74.7%), but was confirmed after hospital admission in only 26.3% of patients. ASA was administered in 51%, UFH in 55%, and both substances in 46.4% of cases. A large proportion of patients received anticoagulants in the pre-hospital setting although the discharge diagnosis was not NSTE-ACS: ASA 62.9%, UFH 66.0%, both substances 56.5%. Conclusions: ASA and UFH are often given to EP-accompanied patients with aCP despite the low accuracy of diagnosis in the pre-hospital setting. Pre-hospital measurement of high-sensitivity troponin T (hs Trop-T) might improve discrimination between NSTE-ACS and other causes of aCP. This is important, as the current guidelines contain no clear recommendations for pre hospital drug treatment in NSTE-ACS.
Keyword:
ACUTE CORONARY SYNDROMES
ACUTE AORTIC DISSECTION
MYOCARDIAL-INFARCTION
INTERNATIONAL REGISTRY
GLOBAL REGISTRY
RISK SCORE
HEPARIN
THROMBOCYTOPENIA
PRETREATMENT
SENSITIVITY
期刊
D
IF:
7.1
论文数:
4.9K
被引数:
9.5K
机构
引用论文
Pre-hospital heparin use for ST-elevation myocardial infarction is safe and improves angiographic outcomes院前使用肝素治疗ST段抬高型心肌梗死是安全的，可改善血管造影结果OAAI
OAAI分享收藏Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)ST段抬高型心肌梗死患者的肝素预处理: 瑞典冠状动脉造影和血管成形术登记处 (SCAAR) 的报告.png)
EUROINTERVENTIONOAAI
EUROINTERVENTIONIF9.5
OAAI分享收藏Predictors of major bleeding in acute coronary syndromes:: the Global Registry of Acute Coronary Events (GRACE)急性冠脉综合征大出血的预测因素: 全球急性冠脉事件登记 (GRACE)EUROPEAN HEART JOURNALOAAI
EUROPEAN HEART JOURNALIF35.6
OAAI分享收藏
查看更多内容